Covid-19 manufacturing roundup: Biden pumps $500M into domestic testing production; Valneva mulls production deal
The US Department of Health and Human Services has invested an additional $562 million in US companies to boost the domestic manufacturing of Covid-19 tests and supplies, it announced last week.
A dozen companies were recipients of the funding, which included money to support the manufacturing of pipette tips, protective packaging, swabs and reagents used to detect the virus in samples.
Among the recipients were OraSure Technologies, which received $109 million to retrofit a manufacturing facility and build a new one to up domestic manufacturing for rapid antigen self-tests; Cepheid, which landed $63.8 million to produce plastic over mold; and Nalge Nunc International, a subsidiary of Thermo Fisher Scientific, which took home $192.5 million to ramp pipette tip manufacturing for sample collection and test processing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.